Finerenone (Kerendia) significantly reduced urine albumin-to-creatinine ratio (UACR) by 25% from baseline to 6 months compared with the placebo for patients with type 1 diabetes (T1D) and chronic kidney disease …
Copyright MatchingDonors.com©️ 2025 All rights reserved.